000 01510 a2200385 4500
005 20250514065439.0
264 0 _c20040217
008 200402s 0 0 eng d
022 _a0968-0896
024 7 _a10.1016/s0968-0896(03)00148-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMartinez, Ana
245 0 0 _aBenzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. study of structural requirements for biological activity.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry
_cMay 2003
300 _a2395-402 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntiviral Agents
_xchemical synthesis
650 0 4 _aBenzothiadiazines
_xchemical synthesis
650 0 4 _aCytomegalovirus
_xdrug effects
650 0 4 _aCytopathogenic Effect, Viral
650 0 4 _aHeterocyclic Oxides
_xchemical synthesis
650 0 4 _aHumans
650 0 4 _aModels, Molecular
650 0 4 _aMolecular Conformation
650 0 4 _aNuclear Magnetic Resonance, Biomolecular
650 0 4 _aStructure-Activity Relationship
650 0 4 _aViral Plaque Assay
700 1 _aGil, Carmen
700 1 _aCastro, Ana
700 1 _aPérez, Concepción
700 1 _aPrieto, Columbiana
700 1 _aOtero, Joaquin
773 0 _tBioorganic & medicinal chemistry
_gvol. 11
_gno. 11
_gp. 2395-402
856 4 0 _uhttps://doi.org/10.1016/s0968-0896(03)00148-2
_zAvailable from publisher's website
999 _c12524904
_d12524904